Phthalates Biomarker Identification and Exposure Estimates in a Population of Pregnant Women
- 9 June 2009
- journal article
- research article
- Published by Informa UK Limited in Human and Ecological Risk Assessment: An International Journal
- Vol. 15 (3), 565-578
- https://doi.org/10.1080/10807030902892554
Abstract
Phthalates are known reproductive and developmental toxicants in experimental animals. However, in humans, there are few data on the exposure of pregnant women that can be used to assess the potential developmental exposure experienced by the fetus. We measured several phthalate metabolites in maternal urine, maternal serum, and cord serum samples collected at the time of delivery from 150 pregnant women from central New Jersey. The urinary concentrations of most metabolites were comparable to or less than among the U.S. general population, except for mono(2-ethylhexyl) phthalate (MEHP), mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), and mono(2-ethyl-5-oxohexyl) phthalate (MEOHP), three metabolites of di(2-ethylhexyl) phthalate (DEHP). The median urinary concentrations of MEHHP (109 μ g/l) and MEOHP (95.1 μ g/l) were more than 5 times their population-based concentrations, whereas the median urinary concentration of MEHP was more than 20 times higher. High concentration of MEHP may indicate a recent exposure to the parent chemical DEHP in the hospital shortly before the collection of the samples. Calculation of daily intakes using the urinary biomarker data reveals that none of the pregnant women tested had integrated exposures to DEHP greater than the Agency for Toxic Substances and Disease Registry's minimal risk levels (MRLs chronic 60, intermediate 100 μ g/kg/day). No abnormal birth outcomes (e.g., birth weight, Apgar Score, and gestational age) were noted in those newborns whose mothers had relatively greater exposure to DEHP during the perinatal period than others in this study. Significantly greater concentrations and detection frequencies in maternal urine than in maternal serum and cord serum suggest that the urinary concentrations of the phthalate metabolites may be more reliable biomarkers of exposure than their concentrations in other biological specimens.Keywords
This publication has 39 references indexed in Scilit:
- Factors affecting the evaluation of biomonitoring data for human exposure assessmentInternational Journal of Andrology, 2007
- Di(2‐ethylhexyl)phthalate (DEHP): human metabolism and internal exposure – an update and latest results1International Journal of Andrology, 2006
- Personal Care Product Use Predicts Urinary Concentrations of Some Phthalate MonoestersEnvironmental Health Perspectives, 2005
- A Mixture of the “Antiandrogens” Linuron and Butyl Benzyl Phthalate Alters Sexual Differentiation of the Male Rat in a Cumulative Fashion1Biology of Reproduction, 2004
- Analysis of human urine for fifteen phthalate metabolites using automated solid-phase extractionJournal of Chromatography B, 2004
- A biomarker approach to measuring human dietary exposure to certain phthalate diestersFood Additives & Contaminants, 2001
- Male Reproductive Tract Malformations in Rats Following Gestational and Lactational Exposure to Di(n-butyl) Phthalate: An Antiandrogenic Mechanism?Toxicological Sciences, 1998
- Male Reproductive Tract Malformations in Rats Following Gestational and Lactational Exposure to Di(n-butyl) Phthalate: An Antiandrogenic Mechanism?Toxicological Sciences, 1998
- Environmental Endocrine Disruption: An Effects Assessment and AnalysisEnvironmental Health Perspectives, 1998
- Adverse effects of butyl benzyl phthalate on the reproductive and hematopoietic systems of male ratsToxicology, 1985